We are interested in research collaborations and pre-clinical development agreements with industry partners to extend the applications of Pantherna’s proprietary lipid nanoparticle mRNA expression technology platforms (PTX_LNP™, PTXmRNA™).

We are open to research agreements with academia and biotech that have complementary research interest and corresponding capabilities in selected indications proposed by the respective partner.